Toyobo Co., Ltd. · TSE:3101

Toyobo — Q1 FY3/2023 Earnings Presentation

22 slides from Toyobo's earnings presentation, Aug 8, 2022

  1. Slide 1: Presentation to Investors for the First Quarter Ended June 30, 2022

    August 8, 2022 Presentation to Investors for the First Quarter Ended June 30, 2022 TOYOBO CO., LTD.

  2. Slide 2: Highlights

    Highlights Q1 FY 3/23 Results - Sales increased while operating profit decreased due to the impact of rising raw material and fuel prices despite sales of films achieving growth. - Profit of ¥7.8 bn. (up 26.4%) due to extraordinary income despite operating profit of ¥4.6 bn. (down 50.0%). Profit att

  3. Slide 3: Summary of Results: P&L

    Summary of Results: P&L (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q1 Amount % Net sales 94.6 101.0 + 6.4 + 6.8% Operating profit 9.2 4.6 - 4.6 - 50.0% (Ratio to sales) 9.8 % 4.6 % - - Ordinary profit 7.5 4.3 - 3.1 - 42.0% Extraordinary income and losses - 0.5 6.5 - - Profit attributable to owners of parent 6.2

  4. Slide 4: Analysis in Changes in Operating Profit

    Analysis in Changes in Operating Profit Raw materials and fuel costs 10.0 - 4.9 Prices Volume 8.0 +3.0 - 2.0 Others 6.0 - 0.6 (¥bn.) 9.2 4.0 - Absorption-type merger of TFS - Spunbond, ESS 4.6 2.0 - Responses to the FDA ( - 4.6 ) - Research and development 0.0 Q1 FY 3/22 Q1 FY 3/23 FY 3/22 FY 3/23 Q

  5. Slide 5: Summary of Results: BS

    Summary of Results: BS (B) (A) (¥bn.) Mar. 31, 2021 Mar. 31, 2022 Jun. 30, 2022 (A) - (B) Total assets 491.2 517.8 533.6 + 15.8 Cash and deposits 34.7 27.2 32.5 + 5.3 Inventories 76.3 96.0 103.8 + 7.7 Property, plant and equipment 224.6 227.6 232.1 + 4.5 Net assets 188.6 197.1 204.4 + 7.3 Shareholde

  6. Slide 6: Summary of Results: Segment

    Summary of Results: Segment (¥bn.) Net sales Operating profit Q1 FY 3/22 Q1 FY 3/23 Q1 FY 3/22 Q1 FY 3/23 YOY Films and Functional Materials 45.7 45.3 6.8 3.5 - 3.3 Mobility 11.1 11.8 -0.5 -0.8 - 0.3 Lifestyle and Environment 27.7 32.1 1.5 0.3 - 1.2 Life Science 7.5 8.7 1.9 2.1 + 0.3 Real Estate and

  7. Slide 7: Films and Functional Materials

    Films and Functional Materials (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q1 Amount % Net sales 45.7 45.3 - 0.4 - 0.9% Operating profit 6.8 3.5 - 3.3 - 48.3% (OPM) 14.9% 7.8% ‐ ‐ Packaging film - Although shipments were strong, there was a time lag between high raw material prices and product price revisions. Sp

  8. Slide 8: Mobility

    Mobility (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q1 Amount % Net sales 11.1 11.8 + 0.7 +6.8% Operating profit - 0.5 - 0.8 - 0.3 ‐ (OPM) - - ‐ ‐ Engineering plastics - Faced challenges both in Japan and overseas due to the impact of high raw material prices in addition to the production curtailment of automobi

  9. Slide 9: Lifestyle and Environment

    Lifestyle and Environment (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q1 Amount % Net sales 27.7 32.1 + 4.4 + 15.8% Operating profit 1.5 0.3 - 1.2 - 81.5% (OPM) 5.4% 0.9% ‐ ‐ Environmental solutions - Sales of equipment for VOC emissions treatment and replacement elements for Lithium-Ion Battery (LIB) separator p

  10. Slide 10: Life Science

    Life Science (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q1 Amount % Net sales 7.5 8.7 + 1.2 + 16.2% Operating profit 1.9 2.1 + 0.3 + 14.7% (OPM) 24.9% 24.6% ‐ ‐ Biotechnology - Sales of enzymes for diagnostic reagents as well as those for genetic testing reagents increased, despite sales of reagents for PCR test

  11. Slide 11: Forecasts for FY 3/23

    Forecasts for FY 3/23 Forecast of operating profit of ¥24.0 bn. and net profit of ¥13.0 bn. based on the impact of raw material and fuel prices remaining high and the prolongation of the production curtailment of automobiles despite expecting effects from increased production of films and increased

  12. Slide 12: Analysis in Changes in Operating Profit

    Analysis in Changes in Operating Profit Raw materials and fuel costs 30.0 - 12.4 Prices Volume Others +9.0 +0.4 - 1.5 25.0 - Responses 20.0 to the FDA - Research and (¥bn.) 15.0 development 28.4 - Packaging film - Depreciation 24.0 - Airbag fabrics etc. 10.0 ( - 4.4 ) - Equipment for VOC emissions t

  13. Slide 13: Forecasts by Segment

    Forecasts by Segment (¥bn.) Net sales Operating profit FY 3/22 FY 3/23 FY 3/22 FY 3/23 Previous YOY forecasts result forecasts result forecasts (May. 2022) Films and Functional Materials 170.3 186.0 19.9 18.5 - 1.4 19.0 Mobility 44.7 53.0 - 1.8 - 2.3 - 0.5 - 1.6 Lifestyle and Environment 114.3 125.0

  14. Slide 14: Appendix

    TOYOBO Appendix

  15. Slide 15: Business Performance

    Business Performance (¥bn.) FY 3/22 FY 3/23 Net sales Q1 Q2 Q3 Q4 Full year Q1 Films and Funcitonal Materials 45.7 40.2 41.4 43.0 170.3 45.3 Mobility 11.1 10.5 10.6 12.6 44.7 11.8 Lifestyle and Environment 27.7 27.0 27.7 31.9 114.3 32.1 Life Science 7.5 8.9 8.2 10.4 35.0 8.7 Real estate and Others 2

  16. Slide 16: Product Topics 1

    Product Topics 1 Polarizer protective films for LCDs “COSMOSHINE SRF” Polyester-based super retarder film Elimination of coloration (rainbow pattern) caused by birefringence while being a stretched film. ◼ Main application: Polarizer protective films for LCD TVs ◼ Strengths: - Superior handling abil

  17. Slide 17: Product Topics 2

    Product Topics 2 Equipment for VOC emissions treatment Equipment for VOC emissions treatment (adsorption and recovery type), etc. equipped with “K-FILTER” A “K-FILTER” is TOYOBO’s proprietary activated carbon fiber, for which TOYOBO was the first in the world to put it into production in 1974 ◼ Appl

  18. Slide 18: Product Topics 3: PCR test-related Products

    Product Topics 3: PCR test-related Products Detection kit for COVID-19 ◼ Strengths: - Uses PCR enzymes that amplify rapidly, copy accurately, and are highly resistant to contaminants - Eliminates work to remove impurities in samples (throat swab, saliva) with unique enzymes, etc., and reduces the pr

  19. Slide 19: Topics: ESG

    Topics: ESG Continued to be selected as one of the constituents of the four global ESG indexes • FTSE Blossom Japan Index • FTSE Blossom Japan Sector Relative Index • MSCI Japan ESG Select Leaders Index • MSCI Japan Empowering Women Index (WIN) Also selected one of the constituents of ‘’S&P/JPX Carb

  20. Slide 20: Notice

    Notice Online meeting with investors (Scheduled) ➢ Life Science Business (Date: Sep. 16, 2022) ➢ Films Business (Date: Sep. 29, 2022) Plan to disclose the presentation material to the Company’s website at a later date. 20

  21. Slide 21: Please Note

    Please Note The business performance forecasts and targets included in the business plans contained in this presentation are based on information known to the Company’s management as of the day of presentation. Please be aware that the content of the future forecasts may differ significantly from ac

  22. Slide 22: ©️ TOYOBO CO., LTD. All rights reserved.

    ©️ TOYOBO CO., LTD. All rights reserved.

Toyobo — Q1 FY3/2023 Earnings Presentation on 6ix